Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 3/20 | 0.58 |
| ▸ | CPT2 | P23786 | 2/20 | 0.58 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HMGCR | P04035 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1409965 | 1.00 | ACLY (0.58) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL1462468 | 1.00 | ACLY (0.58) | ACLYCPT2HSPD1BLMHSPE1 | |
| Cadaverine Tartrate SCHEMBL9398238 | 0.89 | ACLY (0.59) | ACLYCPT2HSPD1BLMHSPE1 | |
| Malic Acid SCHEMBL29107079 | 0.84 | SMN1; SMN2 (0.54) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL13176929 | 0.83 | CPT2 (0.40) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL18283302 | 0.83 | ACLY (0.61) | ACLYCPT2HSPD1BLMHSPE1 | |
| Leucine SCHEMBL935696 | 0.82 | SLC7A5 (0.60) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL17632510 | 0.82 | ACLY (0.50) | ACLYCPT2HSPD1BLMHSPE1 | |
| Leucine SCHEMBL935695 | 0.82 | SLC7A5 (0.60) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL18283331 | 0.81 | CPT2 (0.39) | ACLYCPT2HSPD1BLMHSPE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1601 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005693-A | Application of Jiaweidanzhi Xiaoyao powder or extract thereof in preparation of medicines for treating depression complicated with ulcerative colitis | 河南中医药大学 | 2026-05-12 | — | — | CN | claimed |
| US-12606850-B2 | Synthesis of beta-hydroxyisovalerate and methods of use | Sasya, Inc. (US) | 2026-04-21 | — | — | US | claimed |
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4155395-B1 | POLYPEPTIDE AND METHOD FOR PRODUCING L-LEUCINE USING SAME | CJ CHEILJEDANG CORP (KR) | 2026-03-04 | — | — | EP | claimed |
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-01-08 | — | — | US | claimed |
| EP-3519579-B1 | PROCESSES TO PREPARE ELONGATED 2-KETOACIDS AND C-5-C10 COMPOUNDS THEREFROM VIA GENETIC MODIFICATIONS TO MICROBIAL METABOLIC PATHWAYS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-11-05 | — | — | EP | claimed |
| EP-4618772-A1 | ASPERGILLUS BIOMASS CONTAINING BIOACTIVE METABOLITES | Biozyme Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| US-20250290086-A1 | TISSUE-SPECIFIC PROMOTERS IN PLANTS | ALTRIA CLIENT SERVICES LLC (US) | 2025-09-18 | — | — | US | claimed |
| US-20250282802-A1 | PHOSPHONATE PRODUCTS AND METHODS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2025-09-11 | — | — | US | claimed |
| EP-4606226-A2 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| US-6605142-B1 | Copper, nickel, or manganese carboxylate and colorant; ink jet printing | AVECIA LIMITED (GB) | 2003-08-12 | — | — | US | claimed |
| US-20030143657-A1 | Methods for the identification of inhibitors of 3-isopropylmalate dehydratase as antibiotics | ICORIA, INC. | 2003-07-31 | — | — | US | claimed |
| WO-2003050310-A2 | METHODS FOR THE IDENTIFICATION OF INHIBITORS OF ASPARAGINE SYNTHASE, 5-AMINOLEVULINATE SYNTHASE, HISTIDINOL-PHOSPHATASE, 3-ISOPROPYLMALATE AND THREONINE SYNTHASE AS ANTIBIOTICS | PARADIGM GENETICS, INC. (US) | 2003-06-19 | — | — | WO | claimed |
| US-20030091543-A1 | Therapeutic cell preparation grafts and methods of use thereof | KLEIN MATTHEW B (US) | 2003-05-15 | — | — | US | claimed |
| CN-1373795-A | Chemical composition for ink | AVECIA LTD (GB) | 2002-10-09 | — | — | CN | claimed |
| WO-2001077366-A1 | POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF | CUBIST PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | claimed |
| EP-0095862-B1 | FERMENTATION PROCESS FOR PRODUCTION OF ALPHA-ISOPROPYLMALIC ACID | PFIZER INC. (US) | 1986-07-30 | — | — | EP | claimed |
| EP-0095862-A1 | Fermentation process for production of alpha-isopropylmalic acid | PFIZER INC. (US) | 1983-12-07 | — | — | EP | claimed |
| US-4407953-A | BY YARROWIA LIPOLYTICA | PFIZER INC. (US) | 1983-10-04 | — | — | US | claimed |
| US-4218261-A | B-HYDROXY-B-CARBOXY-ISOCAPROIC ACID | AJINOMOTO COMPANY, INCORPORATED (JP) | 1980-08-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, PTGES2, PTGES | ACLY 2524/4885CPT2 456/4885HSPD1 2417/4885 |
| US-20250282802-A1 | PHOSPHONATE PRODUCTS AND METHODS | CHAMP1, PHOSPHO1, RIOX2 | ACLY 334/4885CPT2 2819/4885HSPD1 2366/4885 |
| US-12606850-B2 | Synthesis of beta-hydroxyisovalerate and methods of use | CYP51A1, CYP4Z1, CYP2U1 | ACLY 598/4885CPT2 1901/4885HSPD1 1768/4885 |
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, HTR6, SCD | ACLY 1651/4885CPT2 1282/4885HSPD1 821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.